Doctor profile · Federal record
Dr. Lindsay Overko, PA-C
Physician Assistant · Athletic Trainer · Surgical Physician Assistant · Concord, NH
- NPI 1972648111
- Accepts Medicare
- MIPS 86.1 / 100 · 2023
- 15 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
248 Pleasant St Ste 2800
Concord, NH 033017529
(603) 415-6464
fax (603) 227-7576
Credentials & registration
- NPI registered
- February 2007 — 19 yrs on file
- Profile last updated
- June 29, 2023
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State licenses (2)
- New Hampshire #0839 · New Hampshire #0325
- Medicaid
- NH #3075343
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1972648111. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
779
Distinct HCPCS
8
Medicare allowed
$42,828
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 198 | 182 | $56 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 154 | 130 | $83 | |
17110 |
Destruction of skin growth, 1-14 growths | 113 | 95 | $57 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 109 | 43 | $2 | |
17000 |
Destruction of precancer skin growth, 1 growth | 103 | 90 | $41 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 43 | 43 | $113 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 39 | 39 | $70 | |
11102 |
Biopsy of related skin growth, first growth | 20 | 20 | $24 |
In context: peer comparison
Among 43 peers in this city , average services per provider: 71. This provider delivers 11× the peer median.Open Payments
Industry payments received
All-time total
$10,633
Transactions
67
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GENZYME CORPORATION | 21 | $6,356.44 | |
| Janssen Biotech, Inc. | 14 | $1,821.66 | |
| Arcutis Biotherapeutics, Inc. | 8 | $1,306.26 | |
| ABBVIE INC. | 9 | $330.48 | |
| Incyte Corporation | 4 | $158.09 | |
| Janssen Scientific Affairs, LLC | 2 | $141.43 | |
| UCB, Inc. | 1 | $115.05 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $103.61 | |
| SANOFI-AVENTIS U.S. LLC | 1 | $99.99 | |
| Galderma Laboratories, L.P. | 1 | $85.74 | |
| Dermavant Sciences, Inc. | 3 | $74.42 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24.00 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $15.80 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
278
Patients
200
Total drug cost
$98,225
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Fluorouracil | Generic | 86 | 80 | $7,604 |
| Triamcinolone Acetonide | Generic | 53 | 41 | $594 |
| Metronidazole | Generic | 24 | 13 | $1,050 |
| Doxycycline Hyclate | Generic | 22 | 12 | $1,429 |
| Clobetasol Propionate | Generic | 21 | 15 | $558 |
| Hydrocortisone | Generic | 19 | 17 | $123 |
| Ketoconazole | Generic | 16 | 11 | $373 |
| Betamethasone Dipropionate | Generic | 13 | 11 | $616 |
| Humira(Cf) Pen (Adalimumab) | Brand | 12 | 0 | $83,736 |
| Tacrolimus | Generic | 12 | 0 | $2,142 |
Hospital affiliations
Frequently asked questions
What is Dr. Lindsay Overko's medical specialty?
Dr. Lindsay Overko practices Physician Assistant in Concord, NH.
Where does Dr. Lindsay Overko practice?
Dr. Lindsay Overko practices at 248 Pleasant St Ste 2800, Concord, NH 033017529. Office phone: 6034156464.
What is Dr. Lindsay Overko's NPI?
Dr. Lindsay Overko's National Provider Identifier (NPI) is 1972648111, issued by NPPES.
Does Dr. Lindsay Overko accept Medicare assignment?
Yes. Dr. Lindsay Overko accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lindsay Overko commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Established patient office or other outpatient visit (HCPCS 99214); Destruction of skin growth, 1-14 growths (HCPCS 17110). Source: CMS Medicare Physician & Other Practitioners file.